Keyphrases
Ovarian Cancer
100%
Missense mutation
100%
TP53 mutation
100%
Ovarian Cancer Patients
100%
Cancer Study
100%
Patient Survival
50%
Primary Surgery
50%
Stage III-IV
50%
Conserved Regions
50%
Radicality
50%
Polymorphism
25%
Epithelial Ovarian Cancer
25%
Single nucleotide Variant
25%
Tumor Tissue
25%
Prognostic Value
25%
Independent Prognostic Factor
25%
Amino Acid Substitution
25%
DNA Sequencing
25%
Missense
25%
Tetranectin
25%
Ovarian Tumor
25%
Tumor Suppressor Gene
25%
Multivariate Cox Regression Analysis
25%
Chromosome 17
25%
P53 Gene
25%
Wild-type p53
25%
Small number of Studies
25%
Polymorphism Analysis
25%
Single-strand Conformation Polymorphism
25%
Short-arm
25%
P53 Wild Type
25%
Medicine and Dentistry
Ovarian Cancer
100%
Protein P53
100%
Missense Mutation
36%
Krukenberg Tumor
9%
Ovarian Tumor
9%
Neoplasm
9%
Arm
9%
Proportional Hazards Model
9%
Prognostic Factor
9%
DNA Sequence
9%
Tetranectin
9%
Amino Acid Substitution
9%
Tumor Suppressor Gene
9%
Chromosome 17
9%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Protein P53
100%
Ovary Carcinoma
9%
Neoplasm
9%
Amino Acid
9%
Tetranectin
9%
Ovary Tumor
9%
Tumor Suppressor Protein
9%
Biochemistry, Genetics and Molecular Biology
P53
100%
Missense Mutation
40%
Wild Type
20%
DNA Sequence
10%
Conformation
10%
Tumor Suppressor Gene
10%
Missense
10%
Amino Acid Substitution
10%
Protein P53
10%
Chromosome 17
10%